Product Description
The global robotic-assisted orthopedic surgery system market was valued at $1.3 billion in 2024. This is expected to increase over the forecast period at a CAGR of 17.1% to reach $3.9 billion.
The full report suite on the global market for robotic-assisted orthopedic surgery systems includes three segments: capital equipment, disposables and other accessories and services and maintenance revenue. Regional volumes of robotic-assisted orthopedic procedures are also reported.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
From 2025 to 2031, the large joint replacement market is expected to witness the highest demand in total knee replacement procedures. Recognizing this significant market potential, orthopedic companies have strategically concentrated their efforts on this high-value segment. Additionally, these companies are actively expanding the clinical applications of robotic-assisted technologies to include shoulder replacement procedures. In 2024, Zimmer Biomet received U.S. Food and Drug Administration (FDA) clearance for the ROSA® Shoulder System, and reached another milestone as they announced successful operation using their system in the same year. The broader adoption of robotic-assisted orthopedic procedures is anticipated to experience substantial growth over the forecast period, to be bolstered further by the upcoming launch of Stryker’s Mako system with shoulder applications in the near future.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ROBOTIC-ASSISTED ORTHOPEDIC SURGERY SYSTEM MARKET TRENDS
In 2024, North America represented the largest proportion of the overall robotic-assisted orthopedic surgery system market, while the Africa represented the smallest. Over the forecast period, all regions are anticipated to grow at a strong double-digit compound annual growth rate (CAGR). Among these markets by region, the Asia-Pacific is anticipated to have the most rapid growth rate, followed by Asia-Pacific.
GLOBAL ROBOTIC-ASSISTED ORTHOPEDIC SURGERY SYSTEM MARKET SHARE INSIGHTS
- Stryker led the robotic-assisted orthopedic surgery marked globally in 2024 through revenue generated by its orthopedic surgical robot, Mako™. The system has been used in well over half a million procedures globally, reflecting the dominance it has gained in the market since Stryker acquired MAKO Surgical Corp in 2013. Stryker also offers its navigation systems, Stryker NAV3i® and NavSuite®3, allowing the company to be present in two competing technologies.
- Smith & Nephew held the second-leading position in the global robotic-assisted orthopedic surgery system market in 2024. The company offers two surgical robots, NAVIO™ and CORI™. CORI™ is an improved, next-generation robot based on NAVIO™’s Now that CORI™ is on the market, NAVIO™ is going to be phased out of the market. In addition to its surgical robots, Smith & Nephew is also present in the orthopedic navigation system market, allowing the company to be present in two competing technologies.
- Zimmer Biomet offers a range of surgical robots that are a part of the ROSA® robotics portfolio. For orthopedics, its product portfolio includes the ROSA® Knee system, ROSA® Partial Knee and ROSA® Hip
GLOBAL ROBOTIC-ASSISTED ORTHOPEDIC SURGERY SYSTEM MARKET SEGMENTATION SUMMARY
- Capital Equipment Market
- Disposable and Other Accessories Market
- Services and Maintenance Revenue Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2031 |
| Quantitative Data | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
